339 participants
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-29
- Start Date:
- 2024-06-29
- Completion:
- 2026-11-02
Conditions
- Cutaneous Lupus Erythematosus
Interventions
- COMBINATION_PRODUCT
- OTHER
No Results Yet